Some excessive bleedings in foetuses and neonates occur because there are too few blood platelets to stop the bleeding. This may be caused by Foetal Neonatal Alloimmune Thrombocytopenia (FNAIT).


is an EU-funded collaborative project aiming to develop a safe new treatment that prevents excessive bleeding in foetuses and newborns caused by FNAIT.


Plasma from women who have had a foetus/child with FNAIT is needed to produce the new drug that can prevent FNAIT. We strongly encourage these women to donate plasma for production of this drug.


The plasma collection center at College Station in Texas has now been trained and is ready to receive PROFNAIT plasma donors. For more information please contact our Plasma Collection Coordinator Kerstin Jaeraas at See MoreSee Less

1 month ago  ·  

We wish all our wonderful donors and collaborators a MERRY CHRISTMAS and HAPPY NEW YEAR! See MoreSee Less

2 months ago  ·